Bowmed Ibisqus is a market leader in the field of generic injectable antibacterial drugs with a range covering the penicillin, cephalosporin, macrolide and quinolone sub therapy groups.

The company was the first to market with generic Piperacillin/Tazobactam in 2008 and continues to expand its portfolio of medicines for the secondary care market.

Bowmed Ibisqus also has a strategic interest in developing a sustainable group of niche and innovative hospital products.

Please contact us if you would like further information regarding the products and services marketed in the UK.





Bowmed Ibisqus
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.